Opendata, web and dolomites


Albumin particles for intra-articular delivery of celecoxib to treat osteoarthritic inflammation.

Total Cost €


EC-Contrib. €






 IA-NANO project word cloud

Explore the words cloud of the IA-NANO project. It provides you a very rough idea of what is the project "IA-NANO" about.

clearance    biomarkers    societal    model    edge    chronic    particles    rat    injected    screening    host    loaded    ddss    disability    predicted    injections    topical    synoviocytes    space    inhibitor    benefit    prescribed    corticosteroids    anti    biocompatible    gain    knee    inflammatory    human    ia    shortcomings    articular    cutting    cyclooxygenase    demographic    albumin    oa    joint    horizon    vitro    hyaluronic    commercial    primary    employability    fourth    un    option    repeated    sustainable    supervisors    molecules    steroidal    medications    pharmaceutics    inject    free    rapid    researcher    candidate    curable    wellbeing    release    translational    health    load    acting    position    inflamed    therapy    outcomes    mechanism    complete    symptomatic    oral    reduce    celecoxib    joints    deciphered    source    drug    toxic    biodegradable    though    world    efficacy    line    local    experts    acid    administration    concentration    bioassay    2020    suboptimal    area    good    osteoarthritis   

Project "IA-NANO" data sheet

The following table provides information about the project.


Organization address
address: BELFIELD
city: DUBLIN
postcode: 4

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 196˙590 €
 EC max contribution 196˙590 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2021-07-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Osteoarthritis (OA) is the most common chronic condition of the joints and is predicted to become the fourth largest cause of disability in the world by 2020. Its complete mechanism is yet to be deciphered. Though it is not curable, several medications are prescribed to manage the symptomatic OA, of which the oral and topical medications have shortcomings and the better option is the intra-articular (IA) delivery of free corticosteroids and hyaluronic acid. However, IA delivery is challenging due to the rapid clearance of the free injected molecules from the joint space and outcomes are suboptimal in terms of efficacy and a need for repeated injections. Our objective therefore is to load a candidate drug in a long-acting delivery system and inject it directly into the inflamed knee of a rat model of OA, following in vitro bioassay screening in primary human synoviocytes. Thus, in this project, we propose to develop non-toxic, biocompatible and biodegradable albumin particles loaded with the non-steroidal anti-inflammatory cyclooxygenase-2 inhibitor, celecoxib. This method is expected to reduce the side-effects associated with oral administration of celecoxib. In addition, it will also increase the drug local concentration in the joint and the controlled release of the drug will lead to reduction of inflammatory biomarkers in joints. The project is in line with the EU’s Horizon 2020 Programme focus area - Health, Demographic Change and Wellbeing and UN Sustainable Development goal - Good Health and Well-Being. It will be carried out by the researcher and supervisors who are experts in DDSs development, OA therapy and translational pharmaceutics. Both the researcher and the host are expected to benefit in this collaboration and the researcher will gain experience that will increase her future employability. The project will have great societal impact and commercial potential and will also help increase Europe’s position as the leading source of cutting-edge research.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IA-NANO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IA-NANO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

NaWaTL (2020)

Narrative, Writing, and the Teotihuacan Language: Exploring Language History Through Phylogenetics, Epigraphy and Iconography

Read More  

MarshFlux (2020)

The effect of future global climate and land-use change on greenhouse gas fluxes and microbial processes in salt marshes

Read More  

STRESS-Mums (2019)

Study on TRansition and Exclusion in Society of Single-Mums

Read More